Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study
2013 · Journal of Translational Medicine · 29 citations
https://doi.org/10.1186/1479-5876-11-17
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
123
Citations
4
h-index
3
i10-index
Ann-Catherine Jörg is an academic researcher. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Neuroblastoma Research and Treatments & Lung Cancer Research Studies. The author has an h-index of 4, co-authored 6 publications.
Click to start Chat